Sofosbuvir/velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis [LB-15]

Borgia SM, Dearden J, Lurie Y. Sofosbuvir/velpatasvir for 12 weeks is safe and effective in patients undergoing dialysis [LB-15]. The Liver Meeting. San Francisco, CA; 2018.

Publication Type:

Conference Proceedings

Authors:

Borgia, Sergio M.; Dearden, J; Lurie, Y

Source:

The Liver Meeting, San Francisco, CA (2018)

Cited On:

Export Citation:
RIS Format
Top